An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer: Continued Avastin Plus Chemotherapy After First Progression in Clinical Practice
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 17 Oct 2017
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Roche
- 12 Oct 2017 Planned End Date changed from 15 Jun 2017 to 30 Nov 2017.
- 12 Oct 2017 Planned primary completion date changed from 15 Jun 2017 to 30 Nov 2017.
- 29 May 2017 Status changed from recruiting to active, no longer recruiting.